Literature DB >> 19001630

Translating new medical therapies into societal benefit: the role of population-based outcome studies.

Christopher M Booth1, William J Mackillop.   

Abstract

Mesh：

Year:  2008        PMID： 19001630     DOI： 10.1001/jama.300.18.2177

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  25 in total

1.  Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

Authors:  Christopher M Booth; Frances A Shepherd; Yingwei Peng; Gail E Darling; Gavin Li; Weidong Kong; William J Mackillop
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

2.  Is there a gender effect in bladder cancer? A population-based study of practice and outcomes.

Authors:  Francis Michael Patafio; D Robert Siemens; Xuejiao Wei; Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 3.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

4.  Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer.

Authors:  Joanne L Yu; Christine Simmons; J Charles Victor; Dolly Han; Sophie Hogeveen; Natasha Leighl; Sunil Verma
Journal:  Oncologist       Date:  2011-08-11

5.  Uptake of novel medical therapies in the general population.

Authors:  C M Booth; B Rapoport
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

6.  Achieving the achievable in muscle-invasive bladder cancer.

Authors:  Christopher M Booth; William J Mackillop
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

7.  Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice.

Authors:  J S Quirt; S Nanji; X Wei; J A Flemming; C M Booth
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

8.  Prognostic factors for stage III colon cancer in patients 80 years of age and older.

Authors:  Bogdan Badic; Maude Oguer; Melanie Cariou; Tiphaine Kermarrec; Servane Bouzeloc; Jean-Baptiste Nousbaum; Michel Robaszkiewicz; Lucille Queneherve
Journal:  Int J Colorectal Dis       Date:  2021-02-02       Impact factor: 2.571

9.  Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres.

Authors:  Y Madarnas; S F Dent; S F Husain; A Robinson; S Alkhayyat; W M Hopman; J L Verreault; T Vandenberg
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

10.  Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study.

Authors:  J Kankesan; F A Shepherd; Y Peng; G Darling; G Li; W Kong; W J Mackillop; C M Booth
Journal:  Curr Oncol       Date:  2013-02       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.